Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

61694

registered interest
date	12/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Genetics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many xx-positive cases have been recorded in the UK in each of the last 30 years.
tabling member constituency	Suffolk Coastal
tabling member printed	Dr Thérèse Coffey
uin	200390
answer	answer is ministerial correction date of answer 17/06/2014 answer text <p>The Food Standards Agency (FSA) advises that no <em>Trichinella</em> infection has been found in United Kingdom domestic livestock in the past 30 years. <em>Trichinella </em>infection in food producing animals is controlled by European Union regulations, which are directly applicable in the UK. UK industry routinely tests export pigs as required by their export markets, and all sows and boars, horses and feral wild boar going through approved establishments for Trichinella (which currently amounts to about 3–4 million pigs a year), alongside a FSA programme of surveillance in wildlife.</p><p> </p><p>Monitoring for evidence of Trichinella infection in foxes has been carried out in the UK since 1999. Foxes are tested because they are a good indicator of the presence of infection. There have been only two incidences of <em>Trichinella Spiralis </em>found in foxes in Northern Ireland, one in 2007 and one in 2009, and just one incident of <em>Trichinella Pseudospiralis</em> in a fox in Great Britain in 2013.</p><p> </p><p>In terms of human infections, Trichinellosis in humans is notifiable to the Department and any case that occurs is investigated and where possible the source of infection is identified. There have been no human cases acquired from meat produced in the UK for more than 30 years.</p><p> </p><p>Ten cases of trichinellosis were diagnosed in the UK between 2000 and 2012, including an outbreak of eight cases in England and Wales in 2000. Eight of these cases were associated with the consumption of imported meat products. The remaining two cases were travel related where infection was acquired abroad: one case in 2001, and the other 2010.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/06/2014 16:26:57 answering member 3918 label Biography information for Jane Ellison
tabling member	4098 label Biography information for Dr Thérèse Coffey

61732

registered interest
date	12/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services: Medway
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many complaints his Department received from members of the public on care and treatment by Medway NHS Foundation Trust between 2005 and 2010.
tabling member constituency	Gillingham and Rainham
tabling member printed	Rehman Chishti
uin	200388
answer	answer is ministerial correction date of answer 17/06/2014 answer text <p>A search of the Department's Ministerial correspondence database has identified 19 items of correspondence from members of the public received between 1 January 2005 and 31 December 2010 which complain about care and treatment at Medway NHS Foundation Trust. This is a minimum figure which represents correspondence received by the Department's Ministerial correspondence unit only.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 17/06/2014 16:23:47 answering member 3918 label Biography information for Jane Ellison
tabling member	3987 label Biography information for Rehman Chishti

61733

registered interest
date	12/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health: Children and Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when the next British Child and Adolescent Mental Health Survey will be carried out.
tabling member constituency	East Worthing and Shoreham
tabling member printed	Tim Loughton
uin	200389
answer	answer is ministerial correction date of answer 17/06/2014 answer text <p>The Department is currently looking at the options available for carrying out a new survey of children and young people's mental health.</p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 17/06/2014 13:40:42 answering member 1439 label Biography information for Norman Lamb
tabling member	114 label Biography information for Tim Loughton

61736

registered interest
date	12/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prostate Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will take steps to prevent NHS England from implementing restrictions on the use of new drugs for advanced prostate cancer, enzalutamide and abiraterone.
tabling member constituency	Stoke-on-Trent South
tabling member printed	Robert Flello
uin	200514
answer	answer is ministerial correction date of answer 17/06/2014 answer text <p>The National Institute for Health and Care Excellence (NICE) published technology appraisal guidance in June 2012 which recommends abiraterone (Zytiga) in its licensed indication for the treatment of castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen, subject to a patient access scheme agreed between the Department and the drug's manufacturer.</p><p> </p><p>NICE is currently appraising (i) abiraterone for the treatment of metastatic hormone relapsed prostate cancer not previously treated with chemotherapy and (ii) enzalutamide for metastatic hormone-relapsed prostate cancer in adults whose disease has progressed during or after docetaxel-containing chemotherapy.</p><p> </p><p>National Health Service commissioners are legally required to fund those treatments recommended by NICE in its technology appraisal guidance.</p><p> </p><p>In the absence of NICE technology appraisal guidance it is for the relevant NHS commissioner to make funding decisions based on an assessment of the available evidence. The NHS Constitution states that patients have the right to expect local decisions on the funding of drugs and treatments 'to be made rationally following a proper consideration of the evidence'.</p><p> </p><p>We understand that abiraterone as a first-line treatment is available through the Cancer Drugs Fund to NHS patients in England who could benefit from it, and that enzalutamide is also available through the Cancer Drugs Fund to patients who meet specified clinical criteria.</p><p> </p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 17/06/2014 14:13:43 answering member 1439 label Biography information for Norman Lamb
tabling member	1569 label Biography information for Robert Flello

61737

registered interest
date	12/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will take steps to increase the transparency of NICE's decisions on the Cancer Drugs Fund to remove any restrictions on treatment use arising from budgetary pressures and increase its level of engagement with members of the public.
tabling member constituency	Stoke-on-Trent South
tabling member printed	Robert Flello
uin	200515
answer	answer is ministerial correction date of answer 17/06/2014 answer text <p>The operation of the Cancer Drugs Fund is the responsibility of NHS England and the National Institute for Health and Care Excellence does not have a role in the management of the Fund.</p><p> </p><p>NHS England has a standard operating procedure for the Fund, which is available at:</p><p> </p><p>www.england.nhs.uk/ourwork/pe/cdf/</p><p><strong> </strong></p><p><strong> </strong></p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 17/06/2014 14:16:39 answering member 1439 label Biography information for Norman Lamb
tabling member	1569 label Biography information for Robert Flello

61738

registered interest
date	12/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services: Children and Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to maintain the quality of services provided by children and adolescent mental health services in the UK.
tabling member constituency	Huddersfield
tabling member printed	Mr Barry Sheerman
uin	200499
answer	answer is ministerial correction date of answer 17/06/2014 answer text <p>NHS England has responsibility for commissioning Tier 4 (in-patient) Child and Adolescent Mental Health Services (CAMHS). Tiers 1-3 CAMHS are commissioned locally by clinical commissioning groups (CCGs). There are a number of measures in place to ensure the quality of Tier 4 CAMHS provided by companies:</p><p> </p><p>- All providers of CAMHS need to be registered with the Care Quality Commission (CQC).</p><p> </p><p>- National service specifications have been developed for Tier 4 CAMHS to which all service providers are required to adhere. These are used as part of the standard National Health Service contract. A copy of these documents can be found on NHS England's website and accessed via the following links:</p><p> </p><p>www.england.nhs.uk/ourwork/commissioning/spec-services/npc-crg/group-c/c07/</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/c07-tier4ch-ado-mh-aut.pdf</p><p> </p><p>- All providers are monitored against the standard contract through evidence based contract meetings. NHS England and the CQC may also undertake visits to the units to assess the quality of service being delivered.</p><p> </p><p>- Where concerns or issues are raised about a particular unit, such matters are referred to the Area Team Quality Surveillance Group, chaired by Directors of Nursing, for consideration and discussion.</p><p> </p><p>- Where there is significant cause for concern, NHS England may restrict or stop referrals to a particular unit. In extreme circumstances, the CQC has the powers to de-register a provider from being able to provide CAMH Services.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb grouped question UIN 200010 question first answered 17/06/2014 14:10:47 answering member 1439 label Biography information for Norman Lamb
tabling member	411 label Biography information for Mr Barry Sheerman

61747

registered interest
date	12/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medical Records: Databases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will carry out and publish a written risk assessment of the care.data programme; for what reason no such written risk assessment has been published; and which Minister in his Department took the decision not to publish such an assessment.
tabling member constituency	Birmingham, Hall Green
tabling member printed	Mr Roger Godsiff
uin	200563
answer	answer is ministerial correction date of answer 17/06/2014 answer text <p>There has been no decision made not to have a risk assessment for the care.data programme. Risks and issues are considered by the care.data programme board at regular meetings.</p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 17/06/2014 13:44:14 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	304 label Biography information for Mr Roger Godsiff

61748

registered interest
date	12/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cystic Fibrosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many adult cystic fibrosis patients were being cared for by specialist centres in each of the last 10 years.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	200612
answer	answer is ministerial correction date of answer 17/06/2014 answer text <p>Information concerning the number of adult cystic fibrosis (CF) patients cared for by specialist centres in each of the last 10 years is not available. This data has only been collected since the introduction of the tariff for CF services in 2011, and in the following table we have provided the number of adult patients cared for in each year since that time:</p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Adult Patients</p></td></tr><tr><td><p>2011</p></td><td><p>3,885</p></td></tr><tr><td><p>2012</p></td><td><p>4,107<br /></p></td></tr><tr><td><p>2013</p></td><td><p>4,244</p></td></tr></tbody></table><p> </p><p>More generally, we expect all CF patients to have a CF specialist in charge of their care and as part of the ongoing support they receive, to be assessed at specialist centres.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 17/06/2014 13:42:24 answering member 1439 label Biography information for Norman Lamb
tabling member	4124 label Biography information for Chi Onwurah

61302

registered interest
date	11/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	General Practitioners
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, which GP practices have been identified by NHS England as potentially losing more than £3 per patient in 2014-15 following the withdrawal of the Minimum Practice Income Guarantee.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	200213
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>NHS England has published an anonymised list of ‘outliers' which can be found at:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2014/02/gp-gms-practices.pdf</p><p> </p><p>Because the information is commercially sensitive, details that could identify individual practices have not been released.</p><p> </p><p>The Minimum Practice Income Guarantee is being phased out over a period of seven years because it is inequitable, and the money released will be reinvested into basic payments made to all General Medical Services practices.</p><p><strong> </strong></p><p>NHS England is supporting the most affected practices.</p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 16/06/2014 13:40:30 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	1506 label Biography information for Andrew Gwynne

61303

registered interest
date	11/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	General Practitioners: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of being able to access a GP appointment within 48 hours on levels of patient satisfaction.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	200214
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>Overall patient satisfaction is driven by a range of factors, including accessing a general practitioner (GP) appointment at a convenient time, ability to see a preferred GP and the quality of the conversation with the GP.</p><p> </p><p>The Government recognises the importance of timely access to general practice. The PM Challenge Fund has allocated £50 million to pilot ways to improve access around the country, to give GPs the flexibility to meet the needs of the local population.</p><p> </p><p>In addition, the new GP contract introduced a new Enhanced Service, which includes a commitment to same day phone consultations with a professional in the GP surgery, where necessary, for the most at risk in the population.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 16/06/2014 13:27:12 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	1506 label Biography information for Andrew Gwynne